Grantham, Mayo, Van Otterloo & Co (GMO)’s LifeVantage LFVN Stock Holding History

Grantham, Mayo, Van Otterloo & Co (GMO)’s Portfolio LFVN Stock Details LFVN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-10,414	Closed	-$45.3K	–	639
2023 Q2	$45.3K	Hold	10,414	–	–	﹤0.01%	672
2023 Q1	$37.4K	Hold	10,414	–	–	﹤0.01%	689
2022 Q4	$38.7K	Sell	10,414 -8,643	-45%	-$32.9K	﹤0.01%	704
2022 Q3	$71K	Sell	19,057 -44,686	-70%	-$181K	﹤0.01%	702
2022 Q2	$277K	Sell	63,743 -6,300	-9%	-$27.5K	﹤0.01%	680
2022 Q1	$333K	Sell	70,043 -9,000	-11%	-$50K	﹤0.01%	636
2021 Q4	$500K	Hold	79,043	–	–	﹤0.01%	598
2021 Q3	$535K	Hold	79,043	–	–	﹤0.01%	590
2021 Q2	$581K	Buy	79,043 +44,800	+131%	+$366K	﹤0.01%	597
2021 Q1	$320K	Sell	34,243 -3,157	-8%	-$29.5K	﹤0.01%	773
2020 Q4	$349K	Buy	37,400 +16,300	+77%	+$183K	﹤0.01%	727
2020 Q3	$255K	Buy	+21,100	New	+$285K	﹤0.01%	714

Other funds holding LFVN

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

PCM

Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO)'s LFVN Position: Q3 2023 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) sold out of LifeVantage (LFVN) in Q3 2023, closing a stake of 10,414 shares — an estimated $45.3K sold.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in LFVN in Q3 2020 and held it in 12 quarters. The position peaked at $581K in Q2 2021. 53 funds tracked by Wall St. Rank hold LFVN as of Q3 2023.

Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining LifeVantage position as of Q3 2023 after selling out during the quarter.
Grantham, Mayo, Van Otterloo & Co (GMO) sold 10,414 LifeVantage shares in Q3 2023, an estimated $45.3K.
Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in LifeVantage in Q3 2020 and held it in 12 quarters.
Grantham, Mayo, Van Otterloo & Co (GMO)'s LifeVantage position peaked at $581K in Q2 2021.
53 funds tracked by Wall St. Rank held LifeVantage as of Q3 2023.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q3 2023, filed 13 Nov 2023.